Literature DB >> 7519238

Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).

Q Zhu1, M Zhang, D J Rawlings, M Vihinen, T Hagemann, D C Saffran, S P Kwan, L Nilsson, C I Smith, O N Witte, S H Chen, H D Ochs.   

Abstract

The gene responsible for X-linked agammaglobulinemia (XLA) has been recently identified to code for a cytoplasmic tyrosine kinase (Bruton's agammaglobulinemia tyrosine kinase, BTK), required for normal B cell development. BTK, like many other cytoplasmic tyrosine kinases, contains Src homology domains (SH2 and SH3), and catalytic kinase domain. SH3 domains are important for the targeting of signaling molecules to specific subcellular locations. We have identified a family with XLA whose affected members have a point mutation (g-->a) at the 5' splice site of intron 8, resulting in the skipping of coding exon 8 and loss of 21 amino acids forming the COOH-terminal portion of the BTK SH3 domain. The study of three generations within this kinship, using restriction fragment length polymorphism and DNA analysis, allowed identification of the mutant X chromosome responsible for XLA and the carrier status in this family. BTK mRNA was present in normal amounts in Epstein-Barr virus-induced B lymphoblastoid cell lines established from affected family members. Although the SH3 deletion did not alter BTK protein stability and kinase activity of the truncated BTK protein was normal, the affected patients nevertheless have a severe B cell defect characteristic for XLA. The mutant protein was modeled using the normal BTK SH3 domain. The deletion results in loss of two COOH-terminal beta strands containing several residues critical for the formation of the putative SH3 ligand-binding pocket. We predict that, as a result, one or more crucial SH3 binding proteins fail to interact with BTK, interrupting the cytoplasmic signal transduction process required for B cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519238      PMCID: PMC2191618          DOI: 10.1084/jem.180.2.461

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Agammaglobulinemia.

Authors:  O C BRUTON
Journal:  Pediatrics       Date:  1952-06       Impact factor: 7.124

2.  Improved double-stranded DNA sequencing using the linear polymerase chain reaction.

Authors:  V Murray
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

3.  Mapping of the X-linked agammaglobulinemia locus by use of restriction fragment-length polymorphism.

Authors:  S P Kwan; L Kunkel; G Bruns; R J Wedgwood; S Latt; F S Rosen
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.

Authors:  W M Potts; A B Reynolds; T J Lansing; J T Parsons
Journal:  Oncogene Res       Date:  1988

Review 6.  Splicing of messenger RNA precursors.

Authors:  R A Padgett; P J Grabowski; M M Konarska; S Seiler; P A Sharp
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

7.  Epstein-Barr virus-induced lymphoblastoid cell lines derived from the peripheral blood of patients with X-linked agammaglobulinemia can secrete IgM.

Authors:  D Levitt; H Ochs; R J Wedgwood
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

8.  Identification of a closely linked DNA marker, DXS178, to further refine the X-linked agammaglobulinemia locus.

Authors:  S P Kwan; J Terwilliger; R Parmley; G Raghu; L A Sandkuyl; J Ott; H Ochs; R Wedgwood; F Rosen
Journal:  Genomics       Date:  1990-02       Impact factor: 5.736

9.  Amino acid substitutions sufficient to convert the nontransforming p60c-src protein to a transforming protein.

Authors:  J Y Kato; T Takeya; C Grandori; H Iba; J B Levy; H Hanafusa
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

10.  Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases.

Authors:  H D Ochs; S D Davis; R J Wedgwood
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more
  13 in total

1.  Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl.

Authors:  S R Tzeng; Y C Lou; M T Pai; M L Jain; J W Cheng
Journal:  J Biomol NMR       Date:  2000-04       Impact factor: 2.835

2.  B-cell-specific demethylation of BTK, the defective gene in X-linked agammaglobulinemia.

Authors:  O Parolini; J Rohrer; L H Shapiro; M E Conley
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 3.  X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.

Authors:  C I Smith; C M Bäckesjö; A Berglöf; L J Brandén; T Islam; P T Mattsson; A J Mohamed; S Müller; B Nore; M Vihinen
Journal:  Springer Semin Immunopathol       Date:  1998

4.  BTKbase, mutation database for X-linked agammaglobulinemia (XLA)

Authors:  M Vihinen; B H Belohradsky; R N Haire; E Holinski-Feder; S P Kwan; I Lappalainen; H Lehväslaiho; T Lester; A Meindl; H D Ochs; J Ollila; I Vorechovsky; M Weiss; C I Smith
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

5.  Types and effects of protein variations.

Authors:  Mauno Vihinen
Journal:  Hum Genet       Date:  2015-01-24       Impact factor: 4.132

6.  Unusual patterns of exon skipping in Bruton tyrosine kinase are associated with mutations involving the intron 17 3' splice site.

Authors:  R N Haire; Y Ohta; S J Strong; R T Litman; Y Liu; J T Prchal; M D Cooper; G W Litman
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

7.  Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.

Authors:  S R Tzeng; M T Pai; F D Lung; C W Wu; P P Roller; B Lei; C J Wei; S C Tu; S H Chen; W J Soong; J W Cheng
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

8.  BTKbase, mutation database for X-linked agammaglobulinemia (XLA).

Authors:  M Vihinen; O Brandau; L J Brandén; S P Kwan; I Lappalainen; T Lester; J G Noordzij; H D Ochs; J Ollila; S M Pienaar; P Riikonen; B K Saha; C I Smith
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

9.  Assignment of 1H and 15N resonances of murine Tec SH3 domain.

Authors:  S E Pursglove; T D Mulhern; M G Hinds; R S Norton; G W Booker
Journal:  J Biomol NMR       Date:  1998-10       Impact factor: 2.835

10.  BTKbase, mutation database for X-linked agammaglobulinemia (XLA).

Authors:  M Vihinen; T Iwata; C Kinnon; S P Kwan; H D Ochs; I Vorechovský; C I Smith
Journal:  Nucleic Acids Res       Date:  1996-01-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.